Search research articles
Contact Us
Filters
Showing results (61-70 of 119) with videos related to
Page
of 12
Sort By:
Drug Safety
|
November 1, 1996
Clinically significant interactions of psychotropic agents with antipsychotic drugs
M C Meyer, R J Baldessarini, D C Goff, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1985
Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans
A B Straughn, G C Wood, G Raghow, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 22, 1999
The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms
Y Chen, T W McCall, A R Baichwal, et al.
Biopharmaceutics & Drug Disposition
|
March 1, 1986
Bioavailability of seven furosemide tablets in man
A B Straughn, G C Wood, G Raghow, et al.
Biopharmaceutics & Drug Disposition
|
November 1, 1988
Relative bioavailability of a controlled-release albuterol formulation for twice-daily use
R S Sykes, M E Reese, M C Meyer, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1975
Folic acid dosage for chronic hemodialysis patients
V A Skoutakis, S R Acchiardo, M C Meyer, et al.
Journal of Chromatography
|
October 27, 1989
Gas chromatographic-mass spectrometric analysis of plasma nifedipine
K S Patrick, E J Jarvi, A B Straughn, et al.
Obstetrics and Gynecology
|
March 10, 1998
Adenosine diphosphate-induced platelet activation inhibited by magnesium in a dose-dependent manner
W L Leaphart, M C Meyer, E L Capeless, et al.
Journal of Clinical Pharmacology
|
February 1, 1983
Chloramphenicol dosage and pharmacokinetics in infants and children
G J Burckart, F F Barrett, R Della Valle, et al.
Biophysical Journal
|
May 22, 2007
Solubility versus electrostatics: what determines lipid/protein interaction in lung surfactant
M Seifert, D Breitenstein, U Klenz, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 119) with videos related to
Sort By:
Page
of 12
Drug Safety
|
November 1, 1996
Clinically significant interactions of psychotropic agents with antipsychotic drugs
M C Meyer, R J Baldessarini, D C Goff, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1985
Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans
A B Straughn, G C Wood, G Raghow, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 22, 1999
The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms
Y Chen, T W McCall, A R Baichwal, et al.
Biopharmaceutics & Drug Disposition
|
March 1, 1986
Bioavailability of seven furosemide tablets in man
A B Straughn, G C Wood, G Raghow, et al.
Biopharmaceutics & Drug Disposition
|
November 1, 1988
Relative bioavailability of a controlled-release albuterol formulation for twice-daily use
R S Sykes, M E Reese, M C Meyer, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1975
Folic acid dosage for chronic hemodialysis patients
V A Skoutakis, S R Acchiardo, M C Meyer, et al.
Journal of Chromatography
|
October 27, 1989
Gas chromatographic-mass spectrometric analysis of plasma nifedipine
K S Patrick, E J Jarvi, A B Straughn, et al.
Obstetrics and Gynecology
|
March 10, 1998
Adenosine diphosphate-induced platelet activation inhibited by magnesium in a dose-dependent manner
W L Leaphart, M C Meyer, E L Capeless, et al.
Journal of Clinical Pharmacology
|
February 1, 1983
Chloramphenicol dosage and pharmacokinetics in infants and children
G J Burckart, F F Barrett, R Della Valle, et al.
Biophysical Journal
|
May 22, 2007
Solubility versus electrostatics: what determines lipid/protein interaction in lung surfactant
M Seifert, D Breitenstein, U Klenz, et al.
Page
of 12